Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
批准号:
10601466
负责人:
KEVIN S BAKER
金额:
$46.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-05-01 至 2023-11-30
关键词:
AdherenceAdultAdverse effectsAgeBloodBone Marrow Stem CellBone Marrow TransplantationCancer SurvivorCardiovascular DiseasesCardiovascular systemCaringCharacteristicsChronicCollaborationsControl GroupsDataDiabetes MellitusDiseaseDistressDoseEducationGoalsGuidelinesHealthHealth PersonnelHealthcareHematologic NeoplasmsHomeHourInformaticsInfrastructureInstitutionInternationalInternetInterventionKnowledgeLate EffectsLifeLow incomeMalignant NeoplasmsMarrowMental DepressionMetabolic syndromeMethodsMonitorOsteoporosisParticipantPatient advocacyPatientsPhasePublic Health InformaticsQuality of lifeRandomizedRandomized Controlled TrialsRecoveryRecurrenceReportingResearchResearch PersonnelResourcesRiskSecond Primary CancersSelf CareSelf ManagementSurvivorsSymptomsSystemTechnologyTelephoneTestingUmbilical Cord Blood Transplantationactive controlbasecancer riskcancer therapycardiometabolic riskcardiometabolismcohortcostdata registrydata resourcedepressive symptomsdesignefficacy testingemotional distressexperiencehematopoietic cell transplantationhigh riskimprovedinternational centerintervention deliveryintervention participantsmalemobile applicationmortalitynew technologynovelpatient orientedpatient outreachpeople of colorpersonalized medicineprimary outcomeprogramspsychosocialself-management programsexskillssocial mediastandard of caresurvivorshiptelehealthtransplant centerstransplant survivortreatment armweb site
中文摘要
7.项目总结/摘要
到2030年,估计美国将有50万造血细胞移植(HCT)幸存者。HCT
与其他癌症治疗相比,幸存者的晚期死亡率和不良反应率更高。长-
长期并发症包括心血管疾病、代谢综合征和新癌症的高发病率沿着
有心理社会困难,包括癌症相关的痛苦和抑郁。这项建议
整合、扩展和改善了两个成功的HCT生存率计划,
这项研究将填补HCT幸存者护理方面的关键空白,
幸存者护理计划,提供个性化的自我管理技能和互动支持。的
建议的RCT将在HCT幸存者过渡到最需要的时候提供给他们,
在他们的移植中心进行密切监测它将结合联合收割机的在线,社会媒体和移动的应用程序
INSPIRE计划,包括个性化和HCT特异性治疗总结和生存护理计划
(SCP)。信息学将整合国际血液中心的数据和研究执行资源,
骨髓移植研究(CIBMTR)和国家骨髓捐赠者计划(NMDP)。具体目标
1)在对心脏代谢或新发癌症的医疗保健依从性较差的HCT幸存者中
监测和/或升高的癌症相关的痛苦,确定以病人为中心的,自我的,
与活性对照组相比,管理阶梯式护理方案提供了HCT存活率
最佳做法; 2)确定需要远程保健阶梯式护理的干预参与者的特征,
1个月; 3)确定维持干预措施作为国家HCT所需的资源
生存计划,如果通过CIBMTR//NMDP实施(即,费用、专门知识水平和
相对于成本的干预成分)。这些目标将在N=980的多中心RCT中实现
2-5一年HCT幸存者随机分配到一个自我管理,阶梯式护理计划开始与在线
INSPIRE程序加上个性化SCP(以电子方式填充现有CIBMTR数据资源)
并为1个月后未能改善的人增加远程健康自我管理,而不是积极控制
组提供对个性化SCP和控制网站的访问。主要结局将得到改善
在12个月时坚持心脏代谢和第二癌症监测指南和痛苦。的
拟议的干预措施使用可持续的信息管理系统进行研究管理,
干预交付,并通过增加更大的“剂量”,
通过为那些对在线方案没有反应的人增加远程保健阶梯式护理进行干预
一个人如果该计划证明有效,它可以很容易地实施,以提高护理标准
通过利用CIBMTR/NMDP的现有基础设施,在全国范围内为HCT幸存者提供服务。
英文摘要
7. PROJECT SUMMARY/ABSTRACT
By 2030, there will be an estimated half a million hematopoietic cell transplant (HCT) survivors in the US. HCT
survivors have higher rates of late mortality and adverse effects compared to other cancer treatments. Long-
term complications include high rates of cardiovascular disease, metabolic syndrome, and new cancers along
with psychosocial difficulties including elevated cancer-related distress and depression. This proposal
integrates, extends, and improves two successful HCT survivorship programs tested in randomized controlled
trials (RCTs) and will fill a critical gap in care for HCT survivors by providing a novel, technology based
survivorship care program to provide personalized self-management skills and interactive support. The
proposed RCT will be offered to HCT survivors at the point of their greatest need as they transition away from
close monitoring at their transplant centers. It will combine an online, social media and mobile application
INSPIRE program, with a personalized and HCT-specific treatment summary and survivorship care plan
(SCP). Informatics will integrate the data and study conduct resources of the Center for International Blood and
Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP). The specific aims
are to: 1) Among HCT survivors with poor health care adherence to cardiometabolic or new cancer
surveillance and/or elevated cancer-related distress, determine the impact of a patient-centered, self-
management stepped care program compared to an active control group provided access to HCT survivorship
best practices; 2) Determine characteristics of intervention participants who require telehealth stepped care at
1-month; and 3) Determine resources that would be needed to sustain the intervention as a national HCT
survivorship program if implemented through the CIBMTR//NMDP (i.e., costs, level of expertise, and use of
intervention components relative to costs). These aims will be accomplished in a multicenter RCT of N=980
2-5 year HCT survivors randomized to a self-management, stepped care program beginning with the online
INSPIRE program plus a personalized SCP (electronically populated with existing CIBMTR data resources)
and adding telehealth self-management for those who fail to improve after 1 month, versus an active control
group provided access to the personalized SCP and a control website. Primary outcomes will be improved
adherence to cardiometabolic and second cancer surveillance guidelines and distress at 12 months. The
proposed intervention uses a sustainable informatics administration system for study management and
intervention delivery, and potentially improves effect sizes of earlier studies by adding a larger ‘dose’ of the
intervention through the addition of telehealth stepped care for those who do not respond to the online program
alone. If the program demonstrates efficacy it could be readily implemented to improve the standard of care
nationally for HCT survivors by leveraging the existing infrastructure of the CIBMTR/NMDP.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jtct.2020.10.002
发表时间:
2021-03
期刊:
Transplantation and cellular therapy
影响因子:
3.2
作者:
[Chakraborty R, Hill BT, Majeed A, Majhail NS]
通讯作者:
Majhail NS
Opportunities for improving oncology care.
改善肿瘤护理的机会。
DOI:
10.1016/s1470-2045(18)30208-0
发表时间:
2018
期刊:
The Lancet. Oncology
影响因子:
--
作者:
[Syrjala,KarenL]
通讯作者:
Syrjala,KarenL
Socioeconomic Factors and Adherence to Health Care Recommendations in Adolescent and Young Adult Cancer Survivors.
社会经济因素以及青少年和年轻成人癌症幸存者对医疗保健建议的遵守情况。
DOI:
10.1089/jayao.2022.0109
发表时间:
2023
期刊:
Journal of adolescent and young adult oncology
影响因子:
2
作者:
[Hall,AnurekhaG, Syrjala,KarenL, Ketterl,TylerG, Ganz,PatriciaA, Jacobs,LindaA, Palmer,StevenC, Partridge,Ann, Rajotte,EmilyJo, Mueller,BethA, Baker,KScott]
通讯作者:
Baker,KScott
DOI:
10.1017/s1478951516001061
发表时间:
2017-10
期刊:
Palliative & supportive care
影响因子:
2.2
作者:
[Chakraborty R, El-Jawahri AR, Litzow MR, Syrjala KL, Parnes AD, Hashmi SK]
通讯作者:
Hashmi SK
DOI:
10.1016/j.mcna.2017.06.005
发表时间:
2017-11
期刊:
The Medical clinics of North America
影响因子:
--
作者:
[Yi JC, Syrjala KL]
通讯作者:
Syrjala KL
共 14 条
An INteractive Survivorship Program to Improve Healthcare REsources [INSPIRE] for Adolescent and Young Adult (AYA) Cancer Survivors
-
批准号:10603036
-
项目类别:
-
资助金额:$53.09万
-
财政年份:2020
-
负责人:KEVIN S BAKER
-
依托单位:
An INteractive Survivorship Program to Improve Healthcare REsources [INSPIRE] for Adolescent and Young Adult (AYA) Cancer Survivors
-
批准号:10080015
-
项目类别:
-
资助金额:$167.8万
-
财政年份:2020
-
负责人:KEVIN S BAKER
-
依托单位:
Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
-
批准号:9914095
-
项目类别:
-
资助金额:$72.36万
-
财政年份:2017
-
负责人:KEVIN S BAKER
-
依托单位:
Prevention of bone loss after pediatric hematopoietic cell transplantation
-
批准号:8754512
-
项目类别:
-
资助金额:$44.37万
-
财政年份:2014
-
负责人:KEVIN S BAKER
-
依托单位:
Prevention of bone loss after pediatric hematopoietic cell transplantation
-
批准号:9114863
-
项目类别:
-
资助金额:$47.72万
-
财政年份:2014
-
负责人:KEVIN S BAKER
-
依托单位:
Prevention of bone loss after pediatric hematopoietic cell transplantation
-
批准号:9761467
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2014
-
负责人:KEVIN S BAKER
-
依托单位:
Late Effects after Pediatric HSCT: State of the Science, Future Directions
-
批准号:8129911
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2011
-
负责人:KEVIN S BAKER
-
依托单位:
Gene Therapy for Purine Nucleoside Phosphorylase Deficiency (PNP)
-
批准号:7239735
-
项目类别:
-
资助金额:$11.21万
-
财政年份:2007
-
负责人:KEVIN S BAKER
-
依托单位:
Metabolic Syndrome Following Transplant for Leukemia
-
批准号:7937785
-
项目类别:
-
资助金额:$48.61万
-
财政年份:2006
-
负责人:KEVIN S BAKER
-
依托单位:
Metabolic Syndrome Following Transplant for Leukemia
-
批准号:7276060
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2006
-
负责人:KEVIN S BAKER
-
依托单位:
METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
-
批准号:7606034
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2006
-
负责人:KEVIN S BAKER
-
依托单位:
Metabolic Syndrome Following Transplant for Leukemia
-
批准号:7142226
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2006
-
负责人:KEVIN S BAKER
-
依托单位:
Metabolic Syndrome Following Transplant for Leukemia
-
批准号:7658843
-
项目类别:
-
资助金额:$50.11万
-
财政年份:2006
-
负责人:KEVIN S BAKER
-
依托单位:
LONG-TERM FOLLOW-UP OF CHILDREN WITH ACUTE LEUKEMIA WHO UNDERWENT SCT
-
批准号:7375887
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2005
-
负责人:KEVIN S BAKER
-
依托单位:
LONG-TERM FOLLOW-UP OF CHILDREN WITH ACUTE LEUKEMIA WHO UNDERWENT SCT
-
批准号:7206471
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2005
-
负责人:KEVIN S BAKER
-
依托单位:
METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
-
批准号:7375975
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2005
-
负责人:KEVIN S BAKER
-
依托单位:
Long-term Follow-up of Children with Acute Leukemia who Underwent SCT
-
批准号:7041985
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2003
-
负责人:KEVIN S BAKER
-
依托单位:
LATE EFFECTS IN SURVIVORS OF STEM CELL TRANSPLANTATION
-
批准号:6693029
-
项目类别:
-
资助金额:$13.42万
-
财政年份:2001
-
负责人:KEVIN S BAKER
-
依托单位:
LATE EFFECTS IN SURVIVORS OF STEM CELL TRANSPLANTATION
-
批准号:6844327
-
项目类别:
-
资助金额:$13.73万
-
财政年份:2001
-
负责人:KEVIN S BAKER
-
依托单位:
LATE EFFECTS IN SURVIVORS OF STEM CELL TRANSPLANTATION
-
批准号:6522579
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2001
-
负责人:KEVIN S BAKER
-
依托单位:
海外基金